@article{tessoulin:hal-03203334,
TITLE = {Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial},
AUTHOR = {Tessoulin, Benoit and Chiron, David and Thieblemont, Catherine and Oberic, Lucie and Bouadballah, Kamal and Gyan, Emmanuel and Damaj, Gandhi and Ribrag, Vincent and Gressin, Remy and Feugier, Pierre and Casasnovas, Olivier and Zerazhi, Hacene and Lemonnier, Francois and Maisonneuve, Herve and Joubert, Clementine and van den Neste, Eric and Lamy, Thierry and Tilly, Herve and Moreau, Anne and Hermine, Olivier and Le Gouill, Steven},
URL = {https://hal.science/hal-03203334},
JOURNAL = {Bone Marrow Transplantation},
PUBLISHER = {Nature Publishing Group},
VOLUME = {56},
NUMBER = {7},
PAGES = {1700-1709},
YEAR = {2021},
MONTH = Jul, DOI = {10.1038/s41409-020-01198-2},
PDF = {https://hal.science/hal-03203334/file/2021_BMT_Tessoulin_ok.pdf},
HAL_ID = {hal-03203334},
HAL_VERSION = {v1},
}